LAMEA Automated and Closed Cell Therapy Processing Systems Market By type (stem cell therapy, and non-stem cell therapy), By workflow (separation, expansion, apheresis, fill-finish, cryopreservation and others), By scale (Pre-commercial/R&D Scale and Commercial Scale), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Automated and Closed Cell Therapy Processing Systems Market
Market Report Description
The Latin America, Middle East and Africa Automated And Closed Cell Therapy Processing Systems Market would witness market growth of 21.5% CAGR during the forecast period (2021-2027).
Automated systems would allow constant supervision of controlled therapy processing that is being performed for the development of the latest therapeutic platforms. Also, integrated intelligent algorithms also help in offering high accuracy. Companies operating in this industry are highly engaging in the development of infrastructure to support the production of automated systems.
Factors like rising healthcare investments and growing advancements in medical therapies are anticipated to fuel the growth of the regional automated and closed cell therapy processing systems market. In addition, the increase in investment by government institutions and companies for the development of advanced regenerative and cell therapies would fuel the growth of the regional market in the coming years. Also, specification or customization of medicine is becoming more popular across various nations of this region, which would spur the growth of the regional market during the forecast period.
The Brazil market dominated the LAMEA Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $48.4 million by 2027. The Argentina market is poised to grow a CAGR of 22.2% during (2021 - 2027). Additionally, the UAE market would expect a CAGR of 21.2% during (2021 - 2027).
Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale..Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
- Stem Cell Therapy
- Non-Stem Cell Therapy
- Pre-commercial/R&D Scale
- Commercial Scale
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free